Status:
COMPLETED
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
Lead Sponsor:
Organon and Co
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.
Eligibility Criteria
Inclusion
- 6-month history of migraine
- Migraine attacks typically mild when they begin with 1-4 migraine attacks per month
Exclusion
- Heart disease
- High blood pressure
Key Trial Info
Start Date :
August 17 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2005
Estimated Enrollment :
529 Patients enrolled
Trial Details
Trial ID
NCT00092963
Start Date
August 17 2004
End Date
January 14 2005
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.